Research Groups

Recent Publications - 12 most recent publications

1. Motomura K., Mittelbronn M., Paulus W., Brokinkel B., Keyvani K., Sure U., Wrede K., Nakazato Y., Tanaka Y., Nonoguchi N., Pierscianek D., Kim Y.H., Mariani L., Vital A., Perry A., Ohgaki H. (2013) PDGFRA gain in low-grade diffuse gliomas Journal of neuropathology and experimental neurology; 72(1):61-66. PMID: 23242283

2. Badiali M., Gleize V., Paris S., Moi L., Elhouadani S., Arcella A., Morace R., Antonelli M., Buttarelli F.R., Figarella-Branger D., Kim Y.H., Ohgaki H., Mokhtari K., Sanson M., Giangaspero F. (2012) KIAA1549-BRAF fusions and IDH mutations can coexist in diffuse gliomas of adults Brain pathology; 22(6):841-847. PMID: 22591444

3. Kim Y.H., Nonoguchi N., Paulus W., Brokinkel B., Keyvani K., Sure U., Wrede K., Mariani L., Giangaspero F., Tanaka Y., Nakazato Y., Vital A., Mittelbronn M., Perry A., Ohgaki H. (2012) Frequent BRAF gain in low-grade diffuse gliomas with 1p/19q loss Brain pathology; 22(6):834-840. PMID: 22568401

4. Nagaishi M., Paulus W., Brokinkel B., Vital A., Tanaka Y., Nakazato Y., Giangaspero F., Ohgaki H. (2012) Transcriptional factors for epithelial-mesenchymal transition are associated with mesenchymal differentiation in gliosarcoma Brain pathology; 22(5):670-676. PMID: 22288519

5. Motomura K., Mittelbronn M., Paulus W., Brokinkel B., Keyvani K., Sure U., Wrede K., Nakazato Y., Tanaka Y., Pierscianek D., Kim Y.H., Mariani L., Vital A., Ohgaki H. (2012) DMBT1 Homozygous Deletion in Diffuse Astrocytomas Is Associated With Unfavorable Clinical Outcome Journal of neuropathology and experimental neurology; 71(8):702-707. PMID: 22805772

6. Nagaishi M., Kim Y.H., Mittelbronn M., Giangaspero F., Paulus W., Brokinkel B., Vital A., Tanaka Y., Nakazato Y., Legras-Lachuer C., Lachuer J., Ohgaki H. (2012) Amplification of the STOML3, FREM2, and LHFP Genes Is Associated with Mesenchymal Differentiation in Gliosarcoma American journal of pathology; 180(5):1816-1823. PMID: 22538188

7. Lv S.Q., Kim Y.H., Giulio F., Shalaby T., Nobusawa S., Yang H., Zhou Z., Grotzer M., Ohgaki H. (2012) Genetic Alterations in MicroRNAs in Medulloblastomas Brain pathology; 22(2):230-239. PMID: 21793975

8. Nobusawa S., Stawski R., Kim Y.H., Nakazato Y., Ohgaki H. (2011) Amplification of the PDGFRA, KIT and KDR genes in glioblastoma: a population-based study Neuropathology; 31(6):583-588. PMID: 21382095

9. Grunder E., D'Ambrosio R., Fiaschetti G., Abela L., Arcaro A., Zuzak T., Ohgaki H., Lv S.Q., Shalaby T., Grotzer M. (2011) MicroRNA-21 suppression impedes medulloblastoma cell migration European journal of cancer; 47(16):2479-2490. PMID: 21775132

10. Kim Y.H., Lachuer J., Mittelbronn M., Paulus W., Brokinkel B., Keyvani K., Sure U., Wrede K., Nobusawa S., Nakazato Y., Tanaka Y., Vital A., Mariani L., Ohgaki H. (2011) Alterations in the RB1 Pathway in Low-grade Diffuse Gliomas Lacking Common Genetic Alterations Brain pathology; 21(6):645-651. PMID: 21470325

11. Kim Y.H., Pierscianek D., Mittelbronn M., Vital A., Mariani L., Hasselblatt M., Ohgaki H. (2011) TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations Journal of clinical pathology; 64(10):850-852. PMID: 21690245

12. Ohgaki H., Kleihues P. (2011) Genetic profile of astrocytic and oligodendroglial gliomas Brain Tumor Pathol; 28(3):177-183. PMID: 21442241